Bioprocess development of antibody-drug conjugate production for cancer treatment-Reference-Cited by-同舟云学术

Bioprocess development of antibody-drug conjugate production for cancer treatment

Published:2018-10-23 Issue:10 Volume:13 Page:e0206246
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ou Jianfa,Si Yingnan,Goh KahYong,Yasui Norio,Guo Yichen,Song Jiajia,Wang Lizhong,Jaskula-Sztul Renata,Fan Jinda,Zhou Lufang,Liu Runhua,Liu Xiaoguang^ORCID

Funder

National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. Antibody-drug conjugates-a new wave of cancer drugs;H Bouchard;Bioorg Med Chem Lett,2014

2. An emerging playbook for antibody-drug conjugates: Lessons from the laboratory and clinic suggest a strategy for improving efficacy and safety;PM Drake;Curr Opin Chem Biol,2015

3. Small cell lung cancer: Can recent advances in biology and molecular biology be translated into improved outcomes?;PA Jr. Bunn;J Thorac Oncol,2016

4. Final report of the efficacy and safety of gemtuzumab ozogamicin (mylotarg) in patients with cd33-positive acute myeloid leukemia in first recurrence;RA Larson;Cancer,2005

5. Brentuximab vedotin;A Younes;Nat Rev Drug Discov,2012

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic development targeting host heparan sulfate proteoglycan in SARS-CoV-2 infection;Frontiers in Medicine;2024-03-27

2. Advanced biomanufacturing and evaluation of adeno-associated virus;Journal of Biological Engineering;2024-02-15

3. Elucidating Novel Targets for Ovarian Cancer Antibody–Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity;Antibodies;2023-10-16

4. Specific peptide conjugation to a therapeutic antibody leads to enhanced therapeutic potency and thermal stability by reduced Fc dynamics;Scientific Reports;2023-10-02

5. A CD276-Targeted Antibody-Drug Conjugate to Treat Non-Small Lung Cancer (NSCLC);Cells;2023-09-30